Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

A 5029Session 2025-2026

Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors

A5029

Underlined text would be added to current law. Struck-through text would be removed.

Skip to main content

New York State Assembly

Speaker Carl E. Heastie

  • Assembly Members
  • Legislative Info
  • Public Hearings
  • Speaker's Press
  • Assembly Reports
  • Committees & More
  • Bill Search Home
  • Laws
  • Legislative Calendar
  • Public Hearing Schedule
  • Assembly Calendars
  • Assembly Committee Agenda
Javascript must be enabled to properly view this page. Bill No.:  
     
  •  Summary 
  •  
  •  Actions 
  •  
  •  Committee&nbspVotes 
  •  
  •  Floor&nbspVotes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber&nbspVideo/Transcript 

A05029 Summary:

BILL NOA05029
 
SAME ASSAME AS S01795
 
SPONSORJacobson
 
COSPNSR
 
MLTSPNSR
 
Amd ?6816-a, Ed L
 
Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors in certain cases.
Go to top

A05029 Text:

STATE OF NEW YORK ________________________________________________________________________ 5029 2025-2026 Regular Sessions IN ASSEMBLY February 11, 2025 ___________ Introduced by M. of A. JACOBSON -- read once and referred to the Commit- tee on Higher Education AN ACT to amend the education law, in relation to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto- injectors for dispensation by pharmacists The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Section 6816-a of the education law is amended by adding a 2 new subdivision 6 to read as follows: 3 6. (a) Notwithstanding subdivision two of this section or any other 4 section of law to the contrary, when a patient is prescribed a brand 5 name epinephrine auto-injector, a pharmacist may substitute an alternate 6 epinephrine auto-injector containing the same active ingredients, dosage 7 form and strength as the brand name product prescribed, ordered or 8 demanded, regardless of whether the alternate epinephrine auto-injector 9 is included in the latest list of interchangeable drug products for the 10 prescribed epinephrine auto-injector device, provided that: 11 (i) the prescriber does not indicate that the prescription therefor 12 shall be dispensed as written pursuant to paragraph (a) of subdivision 13 six of section sixty-eight hundred ten of this article; 14 (ii) the alternate epinephrine auto-injector available would reflect a 15 lower unit cost to the purchaser; 16 (iii) the pharmacist has advised the purchaser of the availability of 17 an alternate epinephrine auto-injector and obtained consent to dispense 18 the alternate epinephrine auto-injector; and 19 (iv) the pharmacist has counseled the patient or person authorized to 20 act on the patient's behalf on the proper usage and operating features 21 of the alternate epinephrine auto-injector. 22 (b) For purposes of this subdivision "epinephrine auto-injector" shall 23 have the same meaning as provided in paragraph (b) of subdivision one of 24 section three thousand-c of the public health law. 25 § 2. This act shall take effect immediately. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD03148-01-5 Go to top <link href="/styles/noscript_styles.css" rel="stylesheet"/> Sitemap Request Information Directions and Maps

Official text from the New York Legislature. Formatting has been adapted for reading on Ratifi.